ARCHIVES

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

“Flat” Administrative Structure To Include Resource Teams

September 15, 1995

Annual Report Finds Cancer Incidence And Death Rates Fell For First Time.

December 5, 2008

In Brief: Disapproved CCP Wins Appeal; New Review; Trish Greene Named ACS VP For Nursing

February 26, 1988

DCPC Board Approves “Working” Guidelines For Early Detection

October 2, 1987

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975